15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
15th INTERNATIONAL CONGRESS OF PARKINSON'S
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Abstracts<br />
by topic<br />
122<br />
Abstracts by Topic<br />
1022 A rare cause of L-Dopa responsive parkinsonism: The answer lies in<br />
the eyes<br />
H. Ling, L. Massey, M. Lunn, A. Lees (London, United Kingdom)<br />
1023 The parkinsonism-myotonic-myopathy-complex: Development of<br />
parkinsonism in a patient with myotonic dystrophy type 2 (DM2)<br />
P. Lolekha, P.A. Agarwal, M.J. McKeown (Vancouver, British Columbia,<br />
Canada)<br />
1024 Identification of potential biomarkers for patients with<br />
neurodegenerative parkinsonian syndromes using serum cytokine<br />
microarray analysis<br />
P. Mahlknecht, S. Stemberger, J. Rainer, E. Hametner, K. Schanda,<br />
R. Kirchmair, G. Wenning, K. Seppi, W. Poewe, M. Reindl (Innsbruck,<br />
Austria)<br />
1025 Evaluation of the Scopa-Aut questionnaire in MSA patients: Relation<br />
to UMSARS scores and progression over time<br />
N. Damon-Perrière, V. Cochen De Cock, A. Gerdelat-Mas, A. Foubert-<br />
Samier, R. Debs, A. Pavy-Le Traon, O. Rascol, F. Tison, W.G. Meissner<br />
(Pessac, France)<br />
1026 Distinguishing features of speech production and perception in PD<br />
and PSP<br />
F.R. Minnema, Q.J. Almeida, S.G. Adams (Waterloo, Ontario, Canada)<br />
1027 An autopsy case of PARK2 with Lewy body formation<br />
S. Miyakawa, M. Ogino, N. Hattori, S. Murayama, H. Mochizuki<br />
(Sagamihara, Kanagawa, Japan)<br />
1028 Spectrum of phenotypic manifestations in progressive supranuclear<br />
palsy: Where does the border end?<br />
P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)<br />
1029 Could FRM1 premutation develop two phenotypes of parkinsonism<br />
with different pathophysiological mechanism?<br />
E. Peña, M. Llanero, S. Montilla, B. Gonzalez, C. Fernandez (Madrid,<br />
Spain)<br />
1030 Creutzfeldt Jacob disease presenting as progressive supranuclear<br />
palsy<br />
I.N. Petrovic, A. Martin-Bastida, L. Massey, H. Ling, S.S. O’Sullivan,<br />
D.R. Williams, T. Revesz, A.J. Lees, L. Silveira-Moriyama (London,<br />
United Kingdom)<br />
1031 Wearing-off in post-traumatic hemiparkinsonism<br />
P. Pita Lobo, M. Coelho, T. Mestre, M.M. Rosa, J.J. Ferreira (Lisbon,<br />
Portugal)<br />
1032 123 I-FP-CIT SPECT alteration without parkinsonism in SANDO<br />
phenotype due to POLG mutations<br />
I.J. Posada, M.E. Gallardo, C. Domínguez, H. Rivera, A. Cabello,<br />
J. Arenas, M.A. Martín, R. Garesse, B. Borstein (Madrid, Spain)<br />
1033 The variable phenotype of Fragile X tremor ataxia syndrome<br />
(FXTAS)<br />
K. Roberts, K. O’Rourke, B. Magennis, S. Cronin, T. Lynch (Dublin,<br />
Ireland)<br />
1034 DJ-1 concentrations in CSF from patients with parkinsonian<br />
syndromes<br />
L. Salvesen, S. Bech, A.-M. Lokkegaard, L.E. Hjermind, J.E. Nielsen,<br />
B. Pakkenberg, S. Pålhagen, P. Svenningsson, J. Tanassi, N. Heegaard,<br />
K. Winge (Copenhagen NV, Denmark)<br />
1035 Treating the patient, not the scan: Two patients with psychogenic<br />
parkinsonism in spite of abnormal PET scans<br />
D. Schneider, E. Haberfeld, S. Fahn (New York, New York, USA)<br />
1036 Brain MRI pituitary signal abnormality in patients with liver<br />
cirrhosis before and after liver transplant<br />
J. Shameklis, S. Scala, P. Hildenbrand, J. Zani, D. Apetauerova<br />
(Burlington, Massachusetts, USA)<br />
1037 Clinical-pathological disagreement in Parkinson’s disease and<br />
multiple system atrophy (MSA)<br />
S.F. Smyth, B.J. Crain, K.-E. Codispoti, B. Orr, S.E. Grill, Z.K. Mari<br />
(Baltimore, Maryland, USA)<br />
1038 Pain sensitivity and spinal nociception in atypical parkinsonian<br />
syndromes<br />
M. Stamelou, H. Dohmann, W. Oertel, J. Möller, V. Mylius (London,<br />
United Kingdom)<br />
1039 Clusters of neuropsychiatric disorders in Parkinson’s disease<br />
E. Stefanova, L. Ziropadja, M. Petrovic, T. Stojkovic, V. Kostic<br />
(Belgrade, Serbia, Serbia)<br />
1040 Acute parkinsonism and jaw opening dystonia secondary to<br />
extrapontine myelinolysis – A case report<br />
K.Y. Tay, L. Tan Chew Seng (Singapore, Singapore)<br />
1041 Sensation or attention? The long-term effects of plantar cutaneous<br />
stimulation during a rehabilitation intervention on gait in<br />
Parkinson’s disease<br />
R.B. van Oostveen, Q.J. Almeida, S.D. Perry (Hamilton, Ontario,<br />
Canada)<br />
1042 Wilson’s disease: Treatment on integrated traditional Chinese<br />
medicinal herbs and western medicine<br />
X.-P. Wang, W. Li, J.-F. Wang (Shanghai, China)<br />
1043 Progression of clinical milestones in multiple system atrophy – An<br />
analysis of the EMSA natural history study<br />
G.K. Wenning, F. Krismer, F. Geser, S. Duerr, K. Seppi, W. Poewe, On<br />
Behalf of the EMSA-SG (Innsbruck, Tirol, Austria)<br />
1044 Immunoglobulin treatment, infections and progress in a patient with<br />
multiple system atrophy<br />
K. Winge, A.L. Clausen, A. Glad, L. Korbo (Copenhagen, Denmark)<br />
1045 Clinical findings of Japanese patients with Parkinson’s disease in our<br />
hospital<br />
A. Yoirtaka, Juntendo Clinical Study Group, H. Mori, Y. Mizuno,<br />
N. Hattori (Bunkyo-ku, Tokyo, Japan)<br />
1046 Diffusion tensor imaging analysis of freezing of gait in patients with<br />
white matter changes<br />
J. Youn, J.W. Cho, W.Y. Lee, J.Y. Ahn, S.T. Kim (Seoul, Korea)<br />
1047 Gene ontology enrichment analysis of parkin interactants<br />
A. Zanon, I. Pichler, A. Rakovic, C. Schwienbacher, A.A. Hicks,<br />
A. Alexa, F.S. Domingues, C. Klein, P.P. Pramstaller (Bolzano, Italy)<br />
1048 Subthalamic deep brain stimulation for Parkinson’s disease:<br />
Correlation of locations of oscillatory activity and optimal site of<br />
stimulation<br />
P. Zhuang, M. Hallett, S. Guo, Y. Zhang, J. Li, Y. Li (Beijing, China)
Change language